Article Text

Download PDFPDF
Case report
Metastatic clear cell endometrial carcinoma: an unusual cause of a common clinical presentation
  1. Oluwadunni Emiloju1,
  2. Nellowe Candelario1 and
  3. Claudia Dourado2
  1. 1Department of Internal Medicine, Albert Einstein Medical Center, Philadelphia, Pennsylvania, USA
  2. 2Hematology Oncology Department, Albert Einstein Medical Center, Philadelphia, Pennsylvania, USA
  1. Correspondence to Dr Oluwadunni Emiloju; emilojuo{at}


A 60-year-old woman presented with melena for 2 weeks. She had undergone hysterectomy and bilateral salpingo-oophorectomy to treat clear cell endometrial carcinoma 10 months before the presentation. She was anaemic and tachycardic; abdominal CT scan revealed a large duodenal mass. Her gastrointestinal bleed was not amenable to endoscopic intervention, so she had emergent laparotomy, pancreaticoduodenectomy with duodenal mass excision. Histopathology confirmed that the duodenal mass was a metastatic deposit from her clear cell endometrial cancer. Postoperatively, she was frail and chose hospice care and she died 90 days postoperatively. Clear cell endometrial cancer is a rare subtype of endometrial cancer, that has a worse prognosis compared with the more common endometrioid subtype. The duodenum is a rare site for metastatic endometrial cancer, and we report this case to alert clinicians to the possibility of metastases to the small intestine in patients with clear cell endometrial cancer.

  • gynecological cancer
  • GI bleeding
  • stomach and duodenum
  • chemotherapy
  • end of life decisions (palliative care)

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors OE and CD identified the case for a case report. All authors developed the case report manuscript and reviewed the work prior to submission.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.